|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.05 USD | -4.96% |
|
+1.61% | +64.68% |
| May. 09 | Definium Therapeutics, Inc., Q1 2026 Earnings Call, May 07, 2026 | |
| May. 07 | Definium Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Capitalization | 2.4B 2.04B 1.87B 1.76B 3.29B 227B 3.32B 22.18B 8.65B 109B 9.02B 8.83B 377B | P/E ratio 2026 * |
-9.56x | P/E ratio 2027 * | -12.2x |
|---|---|---|---|---|---|
| Enterprise value | 2.03B 1.73B 1.58B 1.49B 2.78B 192B 2.81B 18.76B 7.31B 92.26B 7.63B 7.47B 319B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 61.9x |
| Free-Float |
99.05% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Definium Therapeutics, Inc.
| 1 day | -4.96% | ||
| 1 week | +1.61% | ||
| Current month | +0.78% | ||
| 1 month | +2.94% | ||
| 3 months | +27.09% | ||
| 6 months | +88.46% | ||
| Current year | +64.68% |
| 1 week | 21.29 |  | 23.52 |
| 1 month | 20.27 | | 26.25 |
| Current year | 12.88 | | 26.25 |
| 1 year | 6.16 | | 26.25 |
| 3 years | 2.41 | | 26.25 |
| 5 years | 2.12 | | 60.6 |
| 10 years | 1.25 | | 86.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | 37 | 2021-06-08 |
Brandi Roberts
DFI | Director of Finance/CFO | 52 | 2025-06-01 |
Daniel Karlin
CTO | Chief Tech/Sci/R&D Officer | 46 | 2021-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Barrow
BRD | Director/Board Member | 37 | 2021-12-12 |
Andreas Krebs
BRD | Director/Board Member | 67 | 2021-09-28 |
Carol Vallone
CHM | Chairman | 69 | 2021-12-12 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.96% | +1.61% | +258.54% | +570.21% | 2.4B | |
| -0.66% | +0.79% | -17.41% | -14.33% | 43.39B | |
| -1.54% | +6.21% | +34.54% | +27.04% | 34.7B | |
| -0.49% | +1.67% | +250.84% | +462.96% | 30.15B | |
| +0.04% | +13.27% | +19.95% | -3.92% | 29.83B | |
| -2.02% | -1.05% | +30.59% | +26.11% | 28.46B | |
| -3.04% | +8.03% | - | - | 14.74B | |
| -6.96% | +0.55% | +203.99% | +4,495.82% | 14.48B | |
| -0.41% | +0.57% | +134.69% | +112.07% | 12.51B | |
| -0.64% | +0.54% | +5.32% | -4.75% | 12.29B | |
| Average | -2.07% | +3.22% | +102.34% | +630.14% | 22.29B | |
| Weighted average by Cap. | -1.45% | +3.63% | +71.07% | +397.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 34.23M 29.09M 26.62M 25.12M 46.86M 3.23B 47.28M 316M 123M 1.55B 128M 126M 5.36B |
| Net income | -255M -217M -199M -187M -350M -24.12B -353M -2.36B -918M -11.59B -958M -938M -40.01B | -207M -176M -161M -152M -284M -19.57B -286M -1.91B -745M -9.4B -777M -761M -32.45B |
| Net Debt | -371M -315M -289M -272M -508M -35.05B -512M -3.42B -1.33B -16.83B -1.39B -1.36B -58.12B | -287M -244M -223M -210M -393M -27.09B -396M -2.65B -1.03B -13.01B -1.08B -1.05B -44.92B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-08 | 22.05 $ | -4.96% | 2,208,807 |
| 26-05-07 | 23.20 $ | -0.94% | 1,809,367 |
| 26-05-06 | 23.42 $ | +4.55% | 1,512,866 |
| 26-05-05 | 22.40 $ | +2.99% | 1,042,610 |
| 26-05-04 | 21.75 $ | +0.23% | 1,064,350 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DFTX Stock
Select your edition
All financial news and data tailored to specific country editions
